Safe and permissible limits of hepatectomy in obstructive jaundice patients

World Journal of Surgery

Volumn 28, Issue 5, 2004, Pages 475-481

  Takahashi, Tetsuya ^a   Togo, Shinji ^a   Tanaka, Kuniya ^a   Endo, Itaru ^a   Fujii, Yoshiro ^a   Shimada, Hiroshi ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN;

ARTICLE; ARTIFICIAL EMBOLISM; BILIARY TRACT DRAINAGE; CHRONIC HEPATITIS; HUMAN; LIVER CIRRHOSIS; LIVER FUNCTION; LIVER RESECTION; MAJOR CLINICAL STUDY; OBSTRUCTIVE JAUNDICE; SAFETY;

BILIRUBIN; EMBOLIZATION, THERAPEUTIC; HEPATECTOMY; HUMANS; JAUNDICE, OBSTRUCTIVE; LIVER DISEASES; POSTOPERATIVE PERIOD; PREOPERATIVE CARE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 2442670203     PISSN: 03642313     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00268-004-7128-7     Document Type: Article

References (25)

1. Takahashi T, Endo I, Shimada H, et al. Assessment of liver function by prognostic score after relief of obstructive jaundice. J. Hepatobiliary. Pancreat. Surg. 1997;4:269-275
2. Takada T, Yasuda H, Hanyu F. Technique and management of percutaneous transhepatic cholangial drainage for treating an obstructive jaundice. Hepatogastroenterology 1995;42:317-322
3. Cotton PB, Burney PGJ, Mason RR. Transnasal bile duct catheterisation after endoscopic sphincterectomy. Gut 1979;20:285-287
4. Makuuchi M, Thai BL, Takayasu K, et al. Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery 1990;107:521-527
5. Heymsfield SB, Fulenwider T, Nordlinger B, et al. Accurate measurement of liver, kidney and spleen volume and mass by computerized axial tomography. Ann. Intern. Med. 1979;90:185-187
6. Shimada H, Matsuba A, Nimoto S, et al. Liver failure after hepatic resection. Nippon Geka Gakkai Zasshi. 1989;4:566-572
7. Shimada H, Endo I, Takahashi T, et al. Pathophysiology of major hepatic resection and benefits of preoperative portal embolization in preventing hepatic failure. J. Hepatobiliary. Pancreat. Surg. 1997;4:384-390
8. LaMont JT, Isselbacher KJ. Postoperative jaundice. N. Engl. J. Med. 1973;288:305-307
9. Jansen PLM, Muller M. Early events in sepsis-associated cholestasis. Gastroenterology 1999;116:486-488
10. Kubota K, Makuuchi M, Kusaka K, et al. Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors. Hepatology 1997;26:1176-1181
11. Matsushita M, Shimamura T, Kamiyama T, et al. Living donor liver transplantation and postoperative cholestasis from the aspect of relationship between degree of postoperative hyperbilirubinemia and graft size. Tan Sui 2000;21:661-666
12. Shimada M, Takenaka Y, Fujiwara Y, et al. Risk factors linked to post-operative morbidity in patients with hepatocellular carcinoma. Br. J. Surg. 1998;85:195-198
13. Yamanaka N, Okamoto E, Kuwata K, et al. A multiple regression equation for prediction of posthepatectomy liver failure. Ann. Surg. 1984; 200:658-663
14. Capussotti L, Polastri R. Operative risks of major hepatic resections. Hepatogastroenterology 1998;45:187-190
15. Povoski SP, Fong Y, Blumgart LH. Extended left hepatectomy. World J. Surg. 1999;23:1289-1293
16. Midorikawa Y, Kubota K, Takayama T, et al. A comparative study of postoperative complications after hepatectomy in patients with and without chronic liver disease. Surgery 1999;126:484-491
17. Bozzetti F, Gennari L, Regalia E, et al. Morbidity and mortality after surgical resection of liver tumors: analysis of 229 cases. Hepatogastroenterology 1992;39:237-241
18. Okamoto E, Kyo A, Yamanaka N, et al. Prediction of the safe limits of hepatectomy by combined volumetric and functional measurements in patients with impaired hepatic function. Surgery 1984;95:586-592
19. Izawa K, Sasaki M, Tomioka T, et al. Evaluation of ICG Bmax in hepatectomized patients undergoing biliary decompression for obstructive jaundice. Tando 1994;8:197-203
20. Kumazawa K, Otani Y, Kubota K, et al. Study of bilirubin measurement in bile drained from patients with obstructive jaundice. Nippon Shoukaki Geka Gakkai Zasshi 1994;27:1771-1777
21. Nagano I, Kato S, Nimura Y, et al. Hepatic mitochondrial changes in experimental obstructive jaundice complicated by biliary infection. Hepatogastroenterology 1994;41:432-437
22. Hatsuse K, Aoki H, Murayama M, et al. A clinical study of hyperbilirubinemia and pathophysiology after major hepatectomy: comparison with liver with obstructive jaundice, liver with cirrhosis and liver with normal function. Nippon Shoukaki Geka Gakkai Zasshi 1994;27:37-44
23. Rimola A, Soto R, Bory F, et al. Reticuloendothelial system phagocytic activity in cirrhosis and its relation to bacterial infection and prognosis. Hepatology 1984;4:53-58
24. Cheng-Hsi S, Shyh-Haw T, Cheng-Chung W, et al. Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma. Ann. Surg. 1996;223:384-394
25. Nagano Y, Nagahori K, Shimada H, et al. Improved functional reserve of hypertrophied contralateral liver after portal vein ligation in rats. J. Hepatol. 2002;37:72-77